Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Open Access Highly Accessed Research article

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

Marie Hudson*, Janet Pope, Michael Mahler, Solène Tatibouet, Russell Steele, Murray Baron, Canadian Scleroderma Research Group (CSRG) and Marvin J Fritzler

Arthritis Research & Therapy 2012, 14:R50  doi:10.1186/ar3763

Article Metrics

6558
Total accesses


2
BioMed Central citations

Article metric FAQ

Accesses  

  • Last 30 days: 242 accesses
  • Last 365 days: 2704 accesses
  • All time: 6558 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information